| Bioactivity | Eleutheroside E, a principal component of Acanthopanax senticosus, has anti-inflammatory and protective effects in ischemia heart. IC50 value:Target:In vitro: Treatment of 10 μM Eleutheroside E (EE) for 24 h increased basal glucose uptake as well as improved TNF-α-mediated suppression of glucose uptake. [2]In vivo: To investigate the effect of Eleutheroside E (EE) on arthritis, the CIA model in DBA/1 mice was used. Compared to vehicle-treated CIA mice, 15 mg/kg TG treatment and 30 and 60 mg/kg EE treatment obviously decreased the arthritis scores and body weight loss in CIA mice (P<0.01) [1]. | ||||||||||||
| Name | Eleutheroside E | ||||||||||||
| CAS | 39432-56-9 | ||||||||||||
| Formula | C34H46O18 | ||||||||||||
| Molar Mass | 742.72 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Eleutheroside E
CAS: 39432-56-9 F: C34H46O18 W: 742.72
Eleutheroside E, a principal component of Acanthopanax senticosus, has anti-inflammatory and protective effects in ische
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.